| Title： | Expert consensus recommendations for the pharmaceutical treatment of osteoarthritis |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | Clinician |
| Evidence classification method： | Evidence grading and recommendation intensity system of Oxford evidence-based medicine center |
| Development unit： | The First Affiliated Hospital of Harbin Medical University，Osteoarthritis group，Rheumatology society of Chinese Medical Doctor Association |
| Registration time: | 2023-03-15 |
| Registration number： | PREPARE-2023CN161 |
| Purpose of the guideline: | Promote the clinical practice of pharmaceutical therapy in Osteoarthritis patients. |
